Dong-A Socio Holdings KRX:000640KOSPI
동아쏘시오홀딩스 · Korean news coverage and regulatory filings, organized.
In Q2 2026, Dong-A Socio Holdings reported revenue of ₩412bn, up 18.9% year on year, and operating profit of ₩39.0bn. Dong-A Socio Holdings (동아쏘시오홀딩스) appeared in 80 Korean news articles and 2 DART filings over the past seven days. Coverage peaked on Oct 27 with 71 articles. The most common catalyst was earnings (34). It was most often mentioned alongside ST Pharm, 글로벌테크놀로지 and Dong-a ST.
Filing signals Revenue & profit growth Insider buying Supply contract Share pledge Screener
Dong-A Socio Holdings quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩412bn | +18.9% | ₩39.0bn margin 9.4% | ₩28.9bn |
| Q1 2026 | ₩351bn | +6.9% | ₩19.1bn margin 5.5% | ₩20.5bn |
| Q4 2025 derived | ₩372bn | +7.2% | ₩16.0bn margin 4.3% | −₩11.7bn |
| Q3 2025 | ₩383bn | +7.2% | ₩33.3bn margin 8.7% | ₩47.1bn |
| Q2 2025 | ₩347bn | +6.9% | ₩28.2bn margin 8.1% | ₩38.0bn |
| Q1 2025 | ₩328bn | +7.7% | ₩20.4bn margin 6.2% | ₩18.0bn |
| Q4 2024 derived | ₩347bn | +14.7% | ₩21.7bn margin 6.3% | ₩5.3bn |
| Q3 2024 | ₩357bn | +23.4% | ₩22.5bn margin 6.3% | ₩27.5bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Dong-A Socio Holdings top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
- 5
- 6
Latest Dong-A Socio Holdings news Korean headlines
-
동아제약 , 3분기 매출 4,310억원
1 more on this story · 1 outlets
- 동아제약, 3분기 매출 4,310억원 달성...전년比 12.7% 증가팍스경제TV · Oct 28 00:47
-
동아제약, OTC 날개 달고 3분기 매출 '4310억원' 달성
1 more on this story · 1 outlets
- 동아제약 3분기 매출 4310억원 달성뉴스클레임 · Oct 27 16:28
-
동아제약, 3분기 매출 4310억원…일반약·물류 성장에 12.7%↑
3 more on this story · 3 outlets
- 동아제약, 일반약 27% 성장에 3분기 매출 4310억원 달성약사공론 · Oct 27 14:05
- 동아제약, 일반약 성장에 3분기 매출 12.7%↑…역대 최대서울경제 · Oct 27 14:22
- 동아제약, 3분기 매출 4310억원…일반의약품·물류 사업 성장쿠키뉴스 · Oct 27 15:35